| Medical and Health Sciences | Lifetime | 437 | GB 49 | 99.98 |
| Medical and Health Sciences | 2021-2025 | 99 | GB 10 | 99.98 |
| General Health Professions | Lifetime | 23 | GB 6 | 99.96 |
| Health Information Management | Lifetime | 24 | GB 6 | 99.69 |
| Public, Environmental and Occupational Health | Lifetime | 387 | GB 53 | 99.45 |
| Econometrics and Quantitative Economics | Lifetime | 725 | GB 66 | 99.32 |
| Emergency Medical Services | Lifetime | 170 | GB 16 | 98.27 |
| Emergency Medicine | Lifetime | 341 | GB 29 | 97.16 |
| Organizational Behavior and Human Resource Management | Lifetime | 718 | GB 90 | 97.86 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 828 | GB 92 | 96.94 |
| Health | Lifetime | 482 | GB 65 | 96.81 |
| Pharmacy | Lifetime | 329 | GB 34 | 96.00 |
| Geriatrics and Gerontology | Lifetime | 446 | GB 46 | 85.80 |
| General Health Professions | 2021-2025 | 9 | GB 2 | 99.92 |
| Health | 2021-2025 | 47 | GB 11 | 98.76 |
| Emergency Medical Services | 2021-2025 | 32 | GB 3 | 96.87 |
| Public, Environmental and Occupational Health | 2021-2025 | 247 | GB 16 | 97.87 |
| Health Information Management | 2021-2025 | 61 | GB 4 | 95.07 |
| Epidemiology | 2021-2025 | 634 | GB 54 | 94.19 |
| Infectious Diseases | 2021-2025 | 367 | GB 36 | 92.90 |
| Health, Toxicology and Mutagenesis | 2021-2025 | 418 | GB 27 | 92.77 |
| Clinical Psychology | 2021-2025 | 920 | GB 107 | 89.51 |
| Oncology | 2021-2025 | 885 | GB 44 | 84.70 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 543 | GB 55 | 80.90 |
| Psychiatry and Mental health | 2021-2025 | 648 | GB 76 | 78.88 |
| Emergency Medicine | 2021-2025 | 288 | GB 30 | 79.00 |
| Primary Care and Health Outcomes | Lifetime | 3 | GB 1 | 99.89 |
| Chronic Disease Management Strategies | Lifetime | 12 | GB 4 | 99.71 |
| Healthcare Policy and Management | Lifetime | 15 | GB 1 | 99.75 |
| Healthcare Systems and Technology | Lifetime | 8 | GB 3 | 99.71 |
| COVID-19 and healthcare impacts | Lifetime | 37 | GB 9 | 99.00 |
| Health Promotion and Cardiovascular Prevention | Lifetime | 9 | GB 4 | 99.48 |
| Clinical practice guidelines implementation | Lifetime | 50 | GB 10 | 99.17 |
| Healthcare cost, quality, practices | Lifetime | 42 | GB 5 | 98.98 |
| Child and Adolescent Health | Lifetime | 81 | GB 14 | 98.74 |
| Medical Coding and Health Information | Lifetime | 9 | GB 2 | 99.08 |
| Emergency and Acute Care Studies | Lifetime | 153 | GB 19 | 98.86 |
| Vaccine Coverage and Hesitancy | Lifetime | 204 | GB 21 | 98.36 |
| Healthcare Systems and Challenges | Lifetime | 17 | GB 6 | 96.68 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 793 | GB 129 | 98.23 |
| Healthcare Quality and Management | Lifetime | 61 | GB 22 | 97.86 |
| Diabetes Management and Education | Lifetime | 203 | GB 30 | 97.71 |
| Hermeneutics and Narrative Identity | Lifetime | 324 | GB 58 | 93.50 |
| SARS-CoV-2 and COVID-19 Research | Lifetime | 919 | GB 69 | 97.23 |
| Telemedicine and Telehealth Implementation | Lifetime | 126 | GB 21 | 96.92 |
| Electronic Health Records Systems | Lifetime | 136 | GB 13 | 97.56 |
| Global Health Workforce Issues | Lifetime | 216 | GB 23 | 96.85 |
| Mobile Health and mHealth Applications | Lifetime | 294 | GB 33 | 97.03 |
| Patient Satisfaction in Healthcare | Lifetime | 273 | GB 34 | 97.01 |
| Diabetes, Cardiovascular Risks, and Lipoproteins | Lifetime | 750 | GB 67 | 97.59 |
| Global Health Care Issues | Lifetime | 487 | GB 86 | 96.54 |
| Health, Medicine and Society | Lifetime | 906 | GB 52 | 92.86 |
| Obesity and Health Practices | Lifetime | 482 | GB 71 | 95.44 |
| Pharmaceutical Practices and Patient Outcomes | Lifetime | 882 | GB 87 | 94.96 |
| Medical Malpractice and Liability Issues | Lifetime | 591 | GB 69 | 92.87 |
| Antibiotic Use and Resistance | Lifetime | 961 | GB 92 | 94.73 |
| Patient-Provider Communication in Healthcare | Lifetime | 801 | GB 112 | 93.72 |
| Health Literacy and Information Accessibility | Lifetime | 483 | GB 40 | 92.61 |
| Patient Safety and Medication Errors | Lifetime | 603 | GB 68 | 93.73 |
| Hospital Admissions and Outcomes | Lifetime | 285 | GB 21 | 91.50 |
| Health Services Management and Policy | Lifetime | 75 | GB 27 | 91.26 |
| Pharmacovigilance and Adverse Drug Reactions | Lifetime | 379 | GB 36 | 90.89 |
| Social Media in Health Education | Lifetime | 647 | GB 52 | 85.73 |
| Nursing Roles and Practices | Lifetime | 966 | GB 203 | 82.24 |
| E-Learning and COVID-19 | Lifetime | 211 | GB 11 | 25.49 |
| Vaccine Coverage and Hesitancy | 2021-2025 | 29 | GB 3 | 99.09 |
| SARS-CoV-2 and COVID-19 Research | 2021-2025 | 383 | GB 36 | 98.35 |
| Healthcare cost, quality, practices | 2021-2025 | 29 | GB 5 | 96.24 |
| Primary Care and Health Outcomes | 2021-2025 | 61 | GB 7 | 96.89 |
| COVID-19 and healthcare impacts | 2021-2025 | 279 | GB 64 | 95.16 |
| Chronic Disease Management Strategies | 2021-2025 | 110 | GB 32 | 96.15 |
| Global Health Workforce Issues | 2021-2025 | 57 | GB 7 | 95.70 |
| Emergency and Acute Care Studies | 2021-2025 | 165 | GB 14 | 95.33 |
| Telemedicine and Telehealth Implementation | 2021-2025 | 207 | GB 22 | 91.47 |
| Climate Change and Health Impacts | 2021-2025 | 587 | GB 43 | 91.58 |
| Mobile Health and mHealth Applications | 2021-2025 | 467 | GB 36 | 89.47 |
| Healthcare Systems and Challenges | 2021-2025 | 21 | GB 3 | 89.63 |
| Child and Adolescent Health | 2021-2025 | 256 | GB 35 | 85.35 |
| Healthcare Systems and Technology | 2021-2025 | 123 | GB 22 | 84.34 |
| Medical Coding and Health Information | 2021-2025 | 25 | GB 6 | 81.06 |
| Healthcare Policy and Management | 2021-2025 | 729 | GB 42 | 83.96 |
| Electronic Health Records Systems | 2021-2025 | 264 | GB 16 | 80.22 |
| Patient Satisfaction in Healthcare | 2021-2025 | 740 | GB 46 | 73.69 |
| Medical Education and Admissions | 2021-2025 | 402 | GB 35 | 70.92 |
| Clinical Reasoning and Diagnostic Skills | 2021-2025 | 615 | GB 40 | 67.95 |
| Adrenal Hormones and Disorders | 2021-2025 | 798 | GB 67 | 67.32 |
| Racial and Ethnic Identity Research | 2021-2025 | 866 | GB 23 | 61.72 |
| HIV/AIDS Impact and Responses | 2021-2025 | 749 | GB 67 | 50.91 |